These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 24738920)

  • 21. Role of IL-22 in microbial host defense.
    Eidenschenk C; Rutz S; Liesenfeld O; Ouyang W
    Curr Top Microbiol Immunol; 2014; 380():213-36. PubMed ID: 25004820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Opposing Effects of IL-1Ra and IL-36Ra on Innate Immune Response to
    Gao N; Me R; Dai C; Seyoum B; Yu FX
    J Immunol; 2018 Jul; 201(2):688-699. PubMed ID: 29891552
    [No Abstract]   [Full Text] [Related]  

  • 23. Paediatric bacterial keratitis cases in Shanghai: microbiological profile, antibiotic susceptibility and visual outcomes.
    Hong J; Chen J; Sun X; Deng SX; Chen L; Gong L; Cao W; Yu X; Xu J
    Eye (Lond); 2012 Dec; 26(12):1571-8. PubMed ID: 23079751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Scanning electron microscopy of the early host inflammatory response in experimental Pseudomonas keratitis and contact lens wear.
    Lawin-Brüssel CA; Refojo MF; Leong FL; Kenyon KR
    Cornea; 1995 Jul; 14(4):355-9. PubMed ID: 7671606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Refractive outcome after severe Pseudomonas aeruginosa Keratitis.
    Huerva V; Sanchez MC
    Optom Vis Sci; 2011 Apr; 88(4):E548-52. PubMed ID: 21187800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute exacerbation of staphylococcal catarrhal infiltration associated with treatment for Pseudomonas aeruginosa keratitis: A case report.
    Bang SP; Jun JH
    Medicine (Baltimore); 2018 Jun; 97(22):e10753. PubMed ID: 29851781
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topical Glycyrrhizin Is Therapeutic for Pseudomonas aeruginosa Keratitis.
    Ekanayaka SA; McClellan SA; Barrett RP; Hazlett LD
    J Ocul Pharmacol Ther; 2018 Apr; 34(3):239-249. PubMed ID: 29236588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bactericidal effect of photo-activated riboflavin using UVA.
    Wiwanitkit V
    Graefes Arch Clin Exp Ophthalmol; 2010 May; 248(5):755; author reply 757-8. PubMed ID: 20091179
    [No Abstract]   [Full Text] [Related]  

  • 29. Flagellin suppresses the inflammatory response and enhances bacterial clearance in a murine model of Pseudomonas aeruginosa keratitis.
    Kumar A; Hazlett LD; Yu FS
    Infect Immun; 2008 Jan; 76(1):89-96. PubMed ID: 17938214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative efficacy of topical moxifloxacin versus ciprofloxacin and vancomycin in the treatment of P. aeruginosa and ciprofloxacin-resistant MRSA keratitis in rabbits.
    Aliprandis E; Ciralsky J; Lai H; Herling I; Katz HR
    Cornea; 2005 Mar; 24(2):201-5. PubMed ID: 15725889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experimental Pseudomonas aeruginosa keratitis in interleukin-10 gene knockout mice.
    Cole N; Krockenberger M; Stapleton F; Khan S; Hume E; Husband AJ; Willcox M
    Infect Immun; 2003 Mar; 71(3):1328-36. PubMed ID: 12595449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of topical ceftazidime on pseudomonas keratitis in rabbits.
    Kremer I; Robinson A; Braffman M; Drucker M; Goldenfeld M; Samra Z; Myszne-Daye N; Gaton D; Savir H
    Cornea; 1994 Jul; 13(4):360-3. PubMed ID: 7924338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overview: Initial antimicrobial therapy for microbial keratitis.
    Daniell M
    Br J Ophthalmol; 2003 Sep; 87(9):1172-4. PubMed ID: 12928292
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison of clinical characteristics and antibiotic susceptibility between Pseudomonas aeruginosa and P. putida keratitis at a tertiary referral center: a retrospective study.
    Cho CH; Lee SB
    BMC Ophthalmol; 2018 Aug; 18(1):204. PubMed ID: 30126384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Attenuation of
    Sharma P; Elofsson M; Roy S
    Virulence; 2020 Dec; 11(1):795-804. PubMed ID: 32507000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathogenic phenotype and genotype of Pseudomonas aeruginosa isolates from spontaneous canine ocular infections.
    Ledbetter EC; Mun JJ; Kowbel D; Fleiszig SM
    Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):729-36. PubMed ID: 18836164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-4 is not critical to pathogenesis in a mouse model of Pseudomonas aeruginosa corneal infection.
    Cole N; Hume E; Khan S; Krockenberger M; Thakur A; Husband AJ; Willcox MD
    Curr Eye Res; 2005 Jul; 30(7):535-42. PubMed ID: 16020287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mammalian target of rapamycin regulates IL-10 and resistance to Pseudomonas aeruginosa corneal infection.
    Foldenauer ME; McClellan SA; Berger EA; Hazlett LD
    J Immunol; 2013 Jun; 190(11):5649-58. PubMed ID: 23626014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of tuftsin in the treatment of experimental Pseudomonas keratitis.
    Smith PC; Zam ZS; Stern GA
    Cornea; 1986; 5(3):181-3. PubMed ID: 2980837
    [No Abstract]   [Full Text] [Related]  

  • 40. [Infectious keratitis in contact lens].
    Adil B; Rajaa D
    Pan Afr Med J; 2014; 17():276. PubMed ID: 25317224
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.